Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Cellular metabolic pathway and nucleic acid synthesis" is not a single molecular target but a collection of interconnected biochemical networks responsible for energy production, macromolecule biosynthesis, and cellular homeostasis. In disease, especially cancer, these pathways are often reprogrammed to support proliferation and survival. Therapeutic strategies target specific enzymes or transporters within these pathways (e.g., antifolates, glutaminase inhibitors), but the broad category itself is not druggable as a single entity. Patient stratification and efficacy monitoring use biomarkers of pathway activity or metabolite levels. Due to the essential nature of core metabolism, targeting these pathways carries risks of toxicity and requires consideration of metabolic context and compensatory mechanisms[1][2][4].
Inhibition of enzyme targets within metabolic pathways, Redirection of metabolic flux, Depletion of nucleotide precursors, Disruption of redox balance
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular metabolic pathway and nucleic acid synthesis.